Heart Failure Clinical Trial
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Summary
Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heartbeat, sometimes a pacemaker is used to control the rate and rhythm of the heartbeat. In this trial, the researchers will test if pacing both the left and right lower half of the heart (ventricles) will:
decrease the number of hospital and clinic visits due to heart failure symptoms
extend life
delay heart failure symptoms as compared to those who are paced in only one ventricle (the right ventricle)
Eligibility Criteria
Inclusion Criteria:
Subject has standard class I or class IIa indication for pacemaker implantation in accordance with ACC/AHA/HRS guidelines
Subjects diagnosed with atrioventricular (AV) block. An AV block is a disturbance when the heart's natural pacemaker sends a message from the atrium (top part of heart) to the ventricle (bottom part of heart) and the message is partially or totally blocked
Subject is receiving first time implant
Subjects with heart failure but no symptoms of it (New York Heart Association [NYHA] Class I), or subjects with mild heart failure that only sometimes interferes with their daily activities (NYHA Class II), or subjects with heart failure that severely limits daily activities (NYHA Class III)
Subjects with documented reduced heart pumping function (left ventricular ejection fraction ≤ 50%) within past 90 days
Subject is at least 18 years old
Subject or authorized legal guardian or representative has signed and dated the Informed Consent
Subject is able to receive a pectoral implant
Subject is expected to remain available for follow-up visits at the study center
Subject is willing and able to comply with the protocol
Exclusion Criteria:
Subject has ever had a previous or has an existing device implant
Subjects with some forms of chest pain or myocardial infarction (heart attack) within the past 30 days
Subjects with coronary bypass within the past 30 days
Subjects with stent within the past 30 days
Subjects with valve repair or replacement within the past 6 months or is indicated for repair or replacement
Subjects with a mechanical right heart valve
Subject is indicated for a biventricular pacing device (CRT-P or CRT-D devices)
Subject is enrolled in a concurrent study which may confound the results of this study (co-enrollment in any concurrent clinical study requires approval of the study manager)
Subject is pregnant, or of child bearing potential and not on a reliable form of birth control
Subjects with a previous heart transplant
Subjects has been classified as NHYA Functional Class IV within prior 90 days (subjects with severe heart failure and should always be resting)
Subject, legal guardian or authorized representative is unable or unwilling to cooperate or give written informed consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Anchorage Alaska, , United States
Peoria Arizona, , United States
Little Rock Arkansas, , United States
Glendale California, , United States
Long Beach California, , United States
Colorado Springs Colorado, , United States
Hollywood Florida, , United States
Jacksonville Florida, , United States
Pensacola Florida, , United States
Tampa Florida, , United States
Park Ridge Illinois, , United States
Rockford Illinois, , United States
Davenport Iowa, , United States
Lexington Kentucky, , United States
Lacombe Louisiana, , United States
Boston Massachusetts, , United States
Grand Rapids Michigan, , United States
Petoskey Michigan, , United States
Ypsilanti Michigan, , United States
Minneapolis Minnesota, , United States
St. Louis Park Minnesota, , United States
Kansas City Missouri, , United States
St. Louis Missouri, , United States
Lincoln Nebraska, , United States
Camden New Jersey, , United States
Hackensack New Jersey, , United States
Ridgewood New Jersey, , United States
Bay Shore New York, , United States
Rochester New York, , United States
Syracuse New York, , United States
West Islip New York, , United States
Cincinnati Ohio, , United States
Cleveland Ohio, , United States
Oklahoma City Oklahoma, , United States
Tulsa Oklahoma, , United States
Danville Pennsylvania, , United States
Doylestown Pennsylvania, , United States
Ephrata Pennsylvania, , United States
Lancaster Pennsylvania, , United States
Philadelphia Pennsylvania, , United States
Wynnewood Pennsylvania, , United States
Wyomissing Pennsylvania, , United States
Providence Rhode Island, , United States
Kingsport Tennessee, , United States
Dallas Texas, , United States
Fort Worth Texas, , United States
Fairfax Virginia, , United States
Norfolk Virginia, , United States
Spokane Washington, , United States
Morgantown West Virginia, , United States
Milwaukee Wisconsin, , United States
Kitchener Ontario, , Canada
Toronto Ontario, , Canada
Montreal Quebec, , Canada
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.